Imperial College London MRC DTP (Medical Research Council Doctoral Training Partnership) PhD student in Clinical Medical Research (Surgery and Cancer). My project focuses on engineering a novel liposomal nanomedicine to target castration-resistant prostate cancer (CRPC).Co-Founder & CEO @ STEMaccess, a comprehensive tutoring service that provides bespoke 1-to-1 academic support and mentoring for students wishing to pursue a STEM or medical career.
-
Co-Founder And CeoStemaccessLondon, Gb -
Visiting ResearcherMonash UniversityLondon, Gb -
Co-Founder & CeoStemaccess Sep 2021 - PresentCo-Founder of STEMaccess, a comprehensive tutoring service that provides individualised 1-to-1 academic support for students wishing to pursue a STEM or medical career.• We provide tutoring and mentoring for all students aspiring to pursue STEM, whether that’s Medicine, Biomedical Sciences, Biology, Chemistry, Physics, Engineering, or other scientific disciplines• We offer comprehensive crash courses covering the entire syllabus for GCSE and A-level STEM subjects. We also host UCAS courses to aid you in writing your personal statement, preparing for interview and securing an offer from your first choice university• We’re passionate about making STEM and Medical careers accessible to all, regardless of background or financial situation. We believe that with the right guidance and mentoring, every student can achieve their full academic potential -
Doctoral ResearcherImperial College London Oct 2021 - PresentMy PhD is funded by the Medical Research Council Doctoral Training Partnership (MRC DTP) and involves engineering liposomal nanomedicines capable of selective and targeted drug release for advanced prostate cancer. My project is joined between the Androgen Signalling and Prostate Cancer Group (led by Professor Charlotte Bevan) and the Membrane Biophysics Group (led by Professor Oscar Ces). During the project, I have:•Gained extensive experience in mammalian cell culture, 3D cell culture, cell viability assays, RT-qPCR, and western blotting •Gained expertise in culturing patient biopsy samples and preparing samples for immunohistochemistry (IHC) •Successfully planned and executed an in vivo study evaluating the biodistribution and toxicology of our liposomal formulations •Developed and optimised a robust, high-performance liquid chromatography (HPLC) pipeline to quantify drug loading into liposomes -
Postgraduate ResearcherImperial College London Jan 2021 - Sep 2021I was a member of the Androgen Signalling and Prostate Cancer group led by Professor Charlotte Bevan. My project involved exploring the mechanism of action of CT7001 (ICEC0942), an orally available ATP-competitive cyclin-dependent kinase 7 (CDK7) inhibitor developed at Imperial College London. During the project, I was able to successfully:• Explore the side-effects of orally administered CT7001 on the small intestine and liver using immunohistochemistry (IHC) staining• Employ site-directed mutagenesis and luciferase-based reporter assays to investigate the importance of post-translational modification of the androgen receptor to the action of CT7001• Evaluate the efficacy of CT7001 against constitutively active androgen receptor mRNA splice variants -
Visiting ScholarUniversity Of California, San Francisco Jan 2024 - Apr 2024I was a visiting scholar at The University of California, San Francisco (UCSF), supervised by Dr Lisa Chesner and Professor Felix Feng. My project involved investigating the regulation of Major Histocompatibility Complex (MHC) class I and II in prostate cancer. Overall, the project aimed to improve the efficacy of immunotherapies, such as immune checkpoint blockade, which has shown limited clinical benefit in immune-cold tumours such as prostate cancer. During the project I successfully planned and performed a CRISPRi flow cytometry screen to identify regulators of MHC. -
Trailblazers In Cancer Research: The Next Generation Early-Career Conference Co-ChairBritish Association For Cancer Research Oct 2022 - Jun 2023Alongside six other committee members, I successfully planned and coordinated an early career cancer conference, providing a platform for emerging professionals in oncology to collaborate and innovate.In my role, I was able to:-Collaborate with esteemed thought leaders, curating an impactful speaker line-up that facilitated engaging panel discussions- Designed and executed unique networking sessions, fostering connections, mentorship, and collaboration among attendees-Raise £13,000 in conference sponsorship from industry partners -
Undergraduate ResearcherMrc London Institute Of Medical Sciences Oct 2019 - Sep 2020London, United KingdomI was part of the Transgenerational Epigenetic Inheritance & Evolution Lab at the MRC London Institute of Medical Sciences, led by Dr Peter Sarkies. My project involved investigating the role of the tricarboxylic acid (TCA) cycle in DNA methyltransferase activity. During the project, I was able to successfully:• Utilised P1 phage transduction to generate in-frame single-gene knockout mutations in several essential TCA cycle genes•Developed a robust and rigorous method for conformation and screening of gene-knockouts• Learned advanced microbiology techniques used to investigate DNA methylation stability in the absence of gene regulation•Verified the activity of DNA methyltransferases (DNMTs) -
Summer School AmbassadorImperial College Business School Jun 2019 - Jul 2019London, United KingdomThe role involved working with three other ambassadors to promote the Imperial College Business School while planning and executing a varied social programme for 150 international students.•Organising and booking ticketed events within London while also planning the logistics•Continually communicating with my team to ensure activities were exciting and that the welfare of students was maintained throughout•Chaperoneining and guided students through busy environments, ensuring no one was lost or left behind •Adjusting to a continually changing timetable and adapting to sudden changes in logistics•Acting as a pastoral mentor that students could depend upon if they needed
Kyle Greenland Skills
Kyle Greenland Education Details
-
Phd Clinical Medicine Research (Surgery And Cancer) -
Distinction -
First Class Honours- 79% -
Heolddu Comprehensive SchoolA Levels
Frequently Asked Questions about Kyle Greenland
What company does Kyle Greenland work for?
Kyle Greenland works for Stemaccess
What is Kyle Greenland's role at the current company?
Kyle Greenland's current role is Co-Founder and CEO.
What schools did Kyle Greenland attend?
Kyle Greenland attended Imperial College London, Imperial College London, Imperial College London, Heolddu Comprehensive School.
What skills is Kyle Greenland known for?
Kyle Greenland has skills like Negotiation, Emotional Intelligence, Team Leadership, Resiliency, Technical Research, Strategic Communication.
Not the Kyle Greenland you were looking for?
-
Kyle Greenland
London -
1sunlife.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial